| Bioactivity | Butyrylcarnitine-d3 (hydrochloride) is deuterium labeled Butyrylcarnitine. Butyrylcarnitine is a metabolite in plasma, acts as a biomarker to improve the diagnosis and prognosis of heart failure, and is indicative of anomalous lipid and energy metabolism[1]. |
| CAS | 2692623-96-2 |
| Formula | C11H19D3ClNO4 |
| Molar Mass | 270.77 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216. [2]. Cheng ML, et al. Metabolic disturbances identified in plasma are associated with outcomes in patients with heart failure: diagnostic and prognostic value of metabolomics. J Am Coll Cardiol. 2015 Apr 21;65(15):1509-20. |
Butyrylcarnitine-d3 hydrochloride
CAS: 2692623-96-2 F: C11H19D3ClNO4 W: 270.77
Butyrylcarnitine-d3 (hydrochloride) is deuterium labeled Butyrylcarnitine. Butyrylcarnitine is a metabolite in plasma, a
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.